NCT05315908 2024-02-28
COVID-19 Testing in Underserved and Vulnerable Populations
University of California, San Diego
Phase NA Terminated
Clinical Trials
20 trialsNCT03801031 2022-12-06
Sexual Dysfunction in Gynecologic Oncology Patients
University of Iowa
Phase 4 Terminated
NCT01117051 2021-06-11
OIC
Takeda
Phase 3 Terminated
NCT02063828 2021-03-05
RELAX
Wake Forest University Health Sciences
Phase NA Terminated
NCT01444911 2019-12-09
Evaluation of The Vaginal Renewalâ„¢ Program in Gynecologic Cancer Patients Experiencing Sexual Dysfunction
University of Wisconsin, Madison
Phase 2 Terminated
NCT02745353 2019-12-09
Naloxegol in Cancer Opioid-Induced Constipation
University of California, San Diego
Phase 2 Terminated
NCT01883908 2019-11-07
GCC1229
University of Maryland, Baltimore
Phase NA Terminated
NCT01189409 2019-08-28
Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients
British Columbia Cancer Agency
Phase 4 Terminated
NCT02300727 2019-05-31
Study to See How Safe Curcumin is and How Well it Works When Used to Treat Mucositis in Patients Getting Chemotherapy
Aurora BayCare Medical Center
Phase 1/2 Terminated
NCT01472445 2019-04-19
Vitamin D and Breast Cancer: Does Weight Make a Difference?
Stanford University
Phase 2 Terminated
NCT02839889 2019-03-05
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
Hospice of Henderson County, Inc.
Phase 4 Terminated
NCT01696643 2018-11-15
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3 Terminated
NCT01901302 2018-11-15
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3 Terminated
NCT01901341 2018-11-15
The Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3 Terminated
NCT02001051 2018-06-14
Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT00352118 2017-12-28
Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
Masonic Cancer Center, University of Minnesota
Phase 2 Terminated
NCT00790296 2017-12-28
Evaluation of Synthetic Thyrotropin Releasing Hormone (TRH) as a Treatment for Cancer-related Fatigue
UConn Health
Phase 2 Terminated
NCT00503776 2017-06-20
Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia
Vanderbilt-Ingram Cancer Center
Phase 2 Terminated
NCT01384292 2015-06-01
Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain
AstraZeneca
Phase 3 Terminated
NCT01682031 2014-08-22
Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy
Roswell Park Cancer Institute
Phase 2 Terminated